Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Behr

Showing results (191-200 of 263) with videos related to

Pageof 27
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1997
Photopenia in chronic vertebral osteomyelitis with technetium-99m-antigranulocyte antibody (BW 250/183)S Gratz, H G Braun, T M Behr, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1997
Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodiesT M Behr, R M Sharkey, M E Juweid, et al.
Bioconjugate Chemistry|July 1, 1997
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft modelR M Sharkey, H Karacay, G L Griffiths, et al.
Bioconjugate Chemistry|May 20, 2004
Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptorsPeter Laverman, Martin Béhé, Wim J G Oyen, et al.
Transplantation Proceedings|September 2, 1998
Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine AT M Behr, K Richter, P Fischer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 27, 2002
Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental resultsMartin Gotthardt, Marc Fischer, Inga Naeher, et al.
Nuclear Medicine Communications|September 1, 1996
Thyroid radiation doses during radioimmunotherapy of CEA-expressing tumours with 131I-labelled monoclonal antibodiesT M Behr, M E Juweid, R M Sharkey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2002
99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infectionStefan Gratz, Huub J J M Rennen, Otto C Boerman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 13, 2006
Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinomaMartin Gotthardt, Martin P Béhé, Daniela Beuter, et al.
Cancer Research|December 11, 1997
Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor typeT M Behr, E Wulst, S Radetzky, et al.
Pageof 27

Showing results (191-200 of 263) with videos related to

Sort By:
Pageof 27
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1997
Photopenia in chronic vertebral osteomyelitis with technetium-99m-antigranulocyte antibody (BW 250/183)S Gratz, H G Braun, T M Behr, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1997
Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodiesT M Behr, R M Sharkey, M E Juweid, et al.
Bioconjugate Chemistry|July 1, 1997
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft modelR M Sharkey, H Karacay, G L Griffiths, et al.
Bioconjugate Chemistry|May 20, 2004
Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptorsPeter Laverman, Martin Béhé, Wim J G Oyen, et al.
Transplantation Proceedings|September 2, 1998
Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine AT M Behr, K Richter, P Fischer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 27, 2002
Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental resultsMartin Gotthardt, Marc Fischer, Inga Naeher, et al.
Nuclear Medicine Communications|September 1, 1996
Thyroid radiation doses during radioimmunotherapy of CEA-expressing tumours with 131I-labelled monoclonal antibodiesT M Behr, M E Juweid, R M Sharkey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2002
99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infectionStefan Gratz, Huub J J M Rennen, Otto C Boerman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 13, 2006
Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinomaMartin Gotthardt, Martin P Béhé, Daniela Beuter, et al.
Cancer Research|December 11, 1997
Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor typeT M Behr, E Wulst, S Radetzky, et al.
Pageof 27